Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:361218.
doi: 10.1155/2012/361218. Epub 2012 Mar 4.

Polymorphisms in HSD17B1: Early Onset and Increased Risk of Alzheimer's Disease in Women with Down Syndrome

Affiliations

Polymorphisms in HSD17B1: Early Onset and Increased Risk of Alzheimer's Disease in Women with Down Syndrome

Joseph H Lee et al. Curr Gerontol Geriatr Res. 2012.

Abstract

Background/Aims. Genetic variants that affect estrogen activity may influence the risk of Alzheimer's disease (AD). In women with Down syndrome, we examined the relation of polymorphisms in hydroxysteroid-17beta-dehydrogenase (HSD17B1) to age at onset and risk of AD. HSD17B1 encodes the enzyme 17β-hydroxysteroid dehydrogenase (HSD1), which catalyzes the conversion of estrone to estradiol. Methods. Two hundred and thirty-eight women with DS, nondemented at baseline, 31-78 years of age, were followed at 14-18-month intervals for 4.5 years. Women were genotyped for 5 haplotype-tagging single-nucleotide polymorphisms (SNPs) in the HSD17B1 gene region, and their association with incident AD was examined. Results. Age at onset was earlier, and risk of AD was elevated from two- to threefold among women homozygous for the minor allele at 3 SNPs in intron 4 (rs676387), exon 6 (rs605059), and exon 4 in COASY (rs598126). Carriers of the haplotype TCC, based on the risk alleles for these three SNPs, had an almost twofold increased risk of developing AD (hazard ratio = 1.8, 95% CI, 1.1-3.1). Conclusion. These findings support experimental and clinical studies of the neuroprotective role of estrogen.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative incidence of Alzheimer's disease by HSD17B1 rs605059 genotype in women with Down syndrome. TT - - - -. CT……. CC—.
Figure 2
Figure 2
(a) Cumulative incidence of Alzheimer's disease by HSD17B1 rs598126 genotype in women with Down syndrome. TT - - - -. CT……. CC—. (b) Cumulative incidence of Alzheimer's disease by HSD17B1 rs676387 genotype in women with Down syndrome. CC - - - -. CT……. TT—.
Figure 3
Figure 3
Linkage disequilibrium patterns for SNPs in HSD17B1.

Similar articles

Cited by

References

    1. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Experimental Neurology. 1985;89(2):484–490. - PubMed
    1. Toran-Allerand CD, Miranda RC, Bentham WDL, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proceedings of the National Academy of Sciences of the United States of America. 1992;89(10):4668–4672. - PMC - PubMed
    1. O’Malley CA, Dean Hautamaki R, Kelley M, Meyer EM. Effects of ovariectomy and estradiol benzoate on high affinity choline uptake, ACh synthesis, and release from rat cerebral cortical synaptosomes. Brain Research. 1987;403(2):389–392. - PubMed
    1. Yamamoto H, Kitawaki J, Kikuchi N, et al. Effects of estrogens on cholinergic neurons in the rat basal nucleus. Journal of Steroid Biochemistry and Molecular Biology. 2007;107(1-2):70–79. - PubMed
    1. Spencer JL, Waters EM, Romeo RD, Wood GE, Milner TA, McEwen BS. Uncovering the mechanisms of estrogen effects on hippocampal function. Frontiers in Neuroendocrinology. 2008;29(2):219–237. - PMC - PubMed

LinkOut - more resources